TrialBMJ open2025

Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.

Marlise Poolman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.